Bioorganic and Medicinal Chemistry Letters p. 6577 - 6581 (2011)
Update date:2022-07-29
Topics:
Savall, Brad M.
Gomez, Laurent
Chavez, Frank
Curtis, Michael
Meduna, Steven P.
Kearney, Aaron
Dunford, Paul
Cowden, Jeffery
Thurmond, Robin L.
Grice, Cheryl
Edwards, James P.
This report discloses the development of a series of tricyclic histamine H4 receptor antagonists. Starting with a low nanomolar benzofuranopyrimidine HTS hit devoid of pharmaceutically acceptable properties, we navigated issues with metabolism and solubility to furnish a potent, stable and water soluble tricyclic histamine H4 receptor antagonist with desirable physiochemical parameters which demonstrated efficacy a mouse ova model.
View MoreShuanghe Bio-Technology Limited(expird)
Contact:+86-571-61710758,18968016640
Address:Jinqiao north road 916# Fuyang
website:http://www.acrospharmatech.com
Contact:+1-3234804688
Address:Flat/RM 1502,Easey Commercial building 253-261 Hennessy Road,Wanchai,HongKong
ShiJiaZhuang Dowell Chemical Co.,Ltd.
website:http://www.dowechem.com
Contact:+86-13463963265
Address:Xiyangling village, high tech Zone, Shijiazhuang,Hebei, China
Contact:+86-18200374913
Address:Hongmei Road, No. 99
Hebei DaPeng Pharm & Chem Co., Ltd.
Contact:86-317-7298678,0576-88861898 88861908
Address:West Songmen Village, East Songmen Town, Wuqiao, Cangzhou, Hebei ,China
Doi:10.1016/j.tetlet.2014.01.076
(2014)Doi:10.1021/ol800028x
(2008)Doi:10.1002/ardp.19592920606
(1959)Doi:10.1039/b718015b
(2008)Doi:10.1021/jo01097a003
(1958)Doi:10.1080/00480169.2002.36312
(1942)